Evil suggests it might be our COB who stripped the Leron label from the social media mentions. He might be right. But I have a certain sympathy for whoever did it. We don't want Leron to be labeled as useless if this one patient, who for all we know could be in pretty dire straits, happens to die. This is, after all, what people with Glioblastoma almost always do. Maybe it is better to do the testing in a clinical environment, where a group of patients are involved, and if Leron pushes the survival rate forward by a few months, it's a success. Right now, if this one patient dies, we look bad.

Meanwhile, best of luck to him. I'm glad he's getting this great MaB, and I think he has a great shot.